S-CELTENSIFY
LIVE

Serial Number

79411977

Owner

Samsung Biologics Co., Ltd.

Attorney

Brian P. Gregg

Filing Date

Oct 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

S-CELTENSIFY Trademark

Serial Number: 79411977 • Registration: 8016858

S-CELTENSIFY is a trademark filed by Samsung Biologics Co., Ltd. on October 16, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Samsung Biologics Co., Ltd. (26 trademarks)

300, Songdo bio-daero,

Entity Type: 03

Trademark Details

Filing Date

October 16, 2024

Registration Date

November 11, 2025

Published for Opposition

September 23, 2025

Goods & Services

Scientific laboratory services for high-efficiency glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; scientific research in the field of molecular analysis; development of biotechnology; biotechnological research; scientific research in the field of biological analysis; biological research; scientific research in the field of biologics; scientific research in the field of biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; testing services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; computer programming in the medical field; medical research laboratories; computer project management services relating to imaging medical data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; providing medical and scientific research information in the field of clinical trial progress; scientific research in the nature of conducting clinical trials for others

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylated drugs; processing of chemicals.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 28, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Oct 31, 2025 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2025 TROA
REFUSAL PROCESSED BY IB
May 9, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR